Belite Bio Announces First Patient Dosed in Phase 2/3 DRAGON II Trial[...]
Natural gas pipeline capacity from the Permian Basin is set to increase
Data from Phase III study OASIS 3 support efficacy and long-term safety[...]
10/09/2024 | Press release | Distributed by Public on 10/09/2024 12:20
Please select the service you want to use:
Smartlinks | Viaderma Inc. | News | Health | Finance | Security Markets | Security Markets | Company News | Securities Issuers | Biotechnology and Medical Research Companies | OTC Markets
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact